| Serial Number | 90160122 |
| Word Mark | SINTBILO |
| Filing Date | Friday, September 4, 2020 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, September 14, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 14, 2021 |
| Description of Mark | The mark consists of a circle from which thirteen rounded shapes protrude, two such shapes appearing to drift off to the left, with one small circle appearing above and to the left of the larger circle, with the word "SINTBILO" appearing to the right. |
| Goods and Services | Pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; vaccines; drugs in the nature of pharmaceutical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer, and antivirals; pharmaceuticals contained in syringe for treating cancer or tumor; chemical preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; dietetic foods adapted for medical use; biological preparations for veterinary purposes for the treatment of tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, cancer and antivirals; diagnostic preparations for medical purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 9, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Innovent Biologics (Suzhou) Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Suzhou City 215123 CN |
| Party Name | Innovent Biologics (Suzhou) Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Suzhou City 215123 CN |
| Event Date | Event Description |
| Tuesday, September 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 14, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 14, 2021 | PUBLISHED FOR OPPOSITION |
| Thursday, August 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, August 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, August 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, August 6, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 6, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Friday, August 6, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, August 6, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Friday, August 6, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, July 23, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 23, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 23, 2021 | ASSIGNED TO LIE |
| Wednesday, July 14, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 20, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 20, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 20, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 12, 2021 | ASSIGNED TO EXAMINER |
| Saturday, October 10, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, October 9, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, September 8, 2020 | NEW APPLICATION ENTERED IN TRAM |